NASDAQ:AMBI AMBI (AMBI) Stock Price, News & Analysis → Truth about Trump you’ve never heard (From Porter & Company) (Ad) Free AMBI Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$4.05▼$4.3050-Day Range N/A52-Week Range N/AVolume708 shsAverage Volume5,855 shsMarket Capitalization$225.52 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisCompetitorsHeadlinesSocial MediaStock AnalysisCompetitorsHeadlinesSocial Media Get AMBI alerts: Email Address Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. About AMBI Stock (NASDAQ:AMBI)Ambit Biosciences Corporation is a biopharmaceutical company. The Company focused on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology, autoimmune and inflammatory diseases by inhibiting kinases that are important drivers for those diseases. The Company’s lead drug candidate, quizartinib, is in Phase IIb clinical development in patients with relapsed/refractory acute myeloid leukemia (AML). The Company’s second drug candidate in clinical development, AC410, is a potent, selective, orally-administered, small molecule inhibitor of Janus kinase 2 (JAK2) that has potential utility for the treatment of autoimmune and inflammatory diseases. The Company’s third program consists of two selective small molecule compounds, AC708 and AC855, which inhibit the colony-stimulating factor-1 receptor (CSF1R), a receptor tyrosine kinase.Read More Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. AMBI Stock News HeadlinesApril 30, 2024 | msn.comNSC Cooperative Society declares 60% net surplusApril 29, 2024 | msn.comStacey Dash Accused Of Trying To Be White Passing After Fans Noticed Whiter ComplexionApril 30, 2024 | Colonial Metals (Ad)The Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.April 25, 2024 | msn.comAmbi Subramaniam and Kaushiki Chakraborty to Minnesotans: Lean in on Indian classical music, it's funApril 23, 2024 | finance.yahoo.comP&G Brands Help This Year's Prospects Be Ready for Anything Ahead of the 2024 NFL DraftApril 23, 2024 | msn.comNetizens Elated After University Graduate Who Celebrated His Graduation with Bad Grammar ApologisesApril 22, 2024 | msn.comNine of Sydney’s best Indian eateries and restaurantsApril 20, 2024 | msn.comComposer Shantanu Moitra's Transformative 3,000 Km Journey Becomes A Captivating YouTube SeriesApril 30, 2024 | Colonial Metals (Ad)The Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.April 16, 2024 | finance.yahoo.comP&G Appoints Neal Reed as Senior Vice President and Managing Director, P&G Australia and New ZealandApril 13, 2024 | msn.comMP: Minor Girl Abducted, Sold Off For ₹90K In Alirajpur; 3 BookedApril 12, 2024 | ca.news.yahoo.comThese 74 robotics companies are hiringApril 11, 2024 | msn.comJaanmoni ki Shaap, Jinto-Gabri's dirty game to Mohanlal's swag: Bigg Boss Malayalam 6 Week 4 reviewApril 9, 2024 | msn.comEast Bay EDA Honors Two Alameda Businesses for InnovationApril 8, 2024 | msn.comAmbidextrous San Diego man shares the benefits of 'Symmetrical Living'April 4, 2024 | msn.comBambi: The Reckoning teaser is stuff children's horror dreams are made ofApril 3, 2024 | au.finance.yahoo.comTide evo, a Revolutionary New Tile Form a Decade in the Making, is Now Available Exclusively in ColoradoApril 3, 2024 | msn.comWB projects only 1.8 percent growth for PakistanMarch 29, 2024 | sg.style.yahoo.comSandy Wu's cafe attacked by two menMarch 29, 2024 | msn.comTaiwanese Star Sandy Wu’s Cafe Targeted With Vandalism AttackMarch 25, 2024 | msn.comHollywood And Fans Are Already Buzzing Over Christopher Nolan's Next FilmMarch 22, 2024 | msn.comHow Hallmark Favorite Tyler Hynes Is Celebrating Women — and His Mom! — with New Movie “Shifting Gears” (Exclusive)March 21, 2024 | cbsnews.comBusinesswomen connect and share secrets to success in HarlemMarch 21, 2024 | msn.comFeel Like You Can Be Both Poly *and* Monogamous? You Might Be AmbiamorousMarch 20, 2024 | msn.comQuantum Tornado Unveils Insights into Black Hole MysteriesMarch 18, 2024 | msn.com14 Best Drugstore Vitamin C Serums for Bright Skin, According to ExpertsMarch 15, 2024 | msn.comNavigating the CosmosSee More Headlines Receive AMBI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AMBI and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/06/2014Today4/30/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorIndustrial Products Industry Sanitary services Sub-IndustryN/A Current SymbolNASDAQ:AMBI CUSIPN/A CIK1131543 Webwww.hpxcorp.com Phone+1-858-3342100FaxN/AEmployees5,041Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio1.33 Current Ratio2.29 Quick Ratio2.23 Sales & Book Value Annual Sales$326.33 million Price / Sales0.74 Cash Flow$6.30 per share Price / Cash Flow0.69 Book Value$10.21 per share Price / Book0.43Miscellaneous Outstanding Shares55,410,000Free Float26,597,000Market Cap$241.03 million OptionableNot Optionable Beta0.61 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key CompetitorsPerma-Fix Environmental ServicesNASDAQ:PESITwin DiscNASDAQ:TWINInflection Point AcquisitionNASDAQ:IPAXQuad/GraphicsNYSE:QUADLuxferNYSE:LXFRView All Competitors AMBI Stock Analysis - Frequently Asked Questions How were AMBI's earnings last quarter? AMBI (NASDAQ:AMBI) issued its quarterly earnings results on Tuesday, May, 6th. The biopharmaceutical company reported ($0.50) EPS for the quarter, missing analysts' consensus estimates of ($0.47) by $0.03. The biopharmaceutical company earned $0.03 million during the quarter, compared to the consensus estimate of $3.50 million. What other stocks do shareholders of AMBI own? Based on aggregate information from My MarketBeat watchlists, some companies that other AMBI investors own include Alexion Pharmaceuticals (ALXN), Amarin (AMRN), Broadcom (BRCM), Cytokinetics (CYTK), Delta Air Lines (DAL), Fortress Biotech (FBIO), FireEye (FEYE), Five Prime Therapeutics (FPRX), Glu Mobile (GLUU) and Halozyme Therapeutics (HALO). This page (NASDAQ:AMBI) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsProtect Your Bank Account Before It’s Too LateWeiss RatingsTruth about Trump you’ve never heardPorter & CompanyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaThe A.I. story nobody is telling you (Read ASAP)TradeSmith4 coins to be the “Next Bitcoin”True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AMBI Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
